Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.
|Number of pages||1|
|Publication status||Published - 2009|
|Event||American Association of Equine Practitioners’ 55th Annual Convention - Mandalay Bay Convention Center, Las Vegas, United States|
Duration: 05 Dec 2009 → 09 Dec 2009
|Conference||American Association of Equine Practitioners’ 55th Annual Convention|
|Period||05/12/09 → 09/12/09|
Raidal, S., Pippia, J., & Noble, G. (2009). Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age. 33-33. Abstract from American Association of Equine Practitioners’ 55th Annual Convention, Las Vegas, United States.